Sericoside
CAS No. 55306-04-2
Sericoside( —— )
Catalog No. M33064 CAS No. 55306-04-2
Sericoside, a triterpenoid compound, is obtained from Terminalia and exhibits potent anti-inflammatory properties. Additionally, sericoside displays robust lipolytic activity, thereby aiding in the reduction of skin wrinkles and improvement of skin texture.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 88 | Get Quote |
|
| 5MG | 121 | Get Quote |
|
| 10MG | 183 | Get Quote |
|
| 25MG | 297 | Get Quote |
|
| 50MG | 426 | Get Quote |
|
| 100MG | 567 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSericoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionSericoside, a triterpenoid compound, is obtained from Terminalia and exhibits potent anti-inflammatory properties. Additionally, sericoside displays robust lipolytic activity, thereby aiding in the reduction of skin wrinkles and improvement of skin texture.
-
DescriptionSericoside is a triterpenoid with anti-inflammatory activity, can be isolated form Terminalia. Sericoside has a strong lipolytic activity. Sericoside can also reduce skin wrinkles and ameliorating skin texture.
-
In VitroSericoside stimulates glycerol release into the cytosol from deposited triglyceride with a dose- and time-dependent manner in fully differentiated 3T3-L1 cells.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorImmunology/Inflammation related
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number55306-04-2
-
Formula Weight666.84
-
Molecular FormulaC36H58O11
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (149.96 mM; Ultrasonic )
-
SMILESC(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)(=O)[C@]23[C@](C=4[C@@](C)(CC2)[C@@]5(C)[C@](CC4)([C@]6(C)[C@@](CC5)([C@](CO)(C)[C@@H](O)[C@H](O)C6)[H])[H])([C@H](O)C(C)(C)CC3)[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rode T, et al. Complex formation of sericoside with hydrophilic cyclodextrins: improvement of solubility and skin penetration in topical emulsion based formulations. Eur J Pharm Biopharm. 2003 Mar;55(2):191-8.?
molnova catalog
related products
-
Casein Kinase Substr...
Casein Kinase Substrates 3 is a substrate of casein kinase.
-
D-F07
D-F07 is a novel fluorescent IRE-1 RNase inhibitor and a tricyclic chromone with potential anticancer activity.
-
Iopromide
Iopromide is a molecule used as a contrast medium. It is marketed under the name Ultravist which is produced by Bayer Healthcare.
Cart
sales@molnova.com